Skip to content

Clinical trials

Embolism trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Embolism Country / region: China Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20081
20211
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Daiichi Sankyo1
First Affiliated Hospital of Zhejiang University1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Sanofi1
The University of Hong Kong1
Tongji Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Embolism6
Thrombosis5
Atrial Fibrillation3
Stroke3
Ischemic Stroke2
Arrhythmias, Cardiac1
Embolic Stroke1
Hemorrhagic Stroke1
Infarction, Anterior Cerebral Artery1
Infarction, Middle Cerebral Artery1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.